Ország: Egyesült Államok
Nyelv: angol
Forrás: NLM (National Library of Medicine)
ceftibuten dihydrate (UNII: 62F4443RWP) (CEFTIBUTEN - UNII:IW71N46B4Y)
Pernix Therapeutics, LLC
ceftibuten dihydrate
CEFTIBUTEN 400 mg
PRESCRIPTION DRUG
New Drug Application
CEDAX- CEFTIBUTEN DIHYDRATE CAPSULE CEDAX- CEFTIBUTEN DIHYDRATE SUSPENSION PERNIX THERAPEUTICS, LLC ---------- CEDAX (CEFTIBUTEN CAPSULES) AND (CEFTIBUTEN FOR ORAL SUSPENSION) FOR ORAL USE ONLY PRODUCT INFORMATION DESCRIPTION CEDAX (ceftibuten capsules) and (ceftibuten for oral suspension) contain the active ingredient ceftibuten as ceftibuten dihydrate. Ceftibuten dihydrate is a semisynthetic cephalosporin antibiotic for oral administration. Chemically, it is (+)-(6R,7R)-7-[(Z)-2-(2-Amino-4-thiazolyl)-4- carboxycrotonamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, dihydrate. Its molecular formula is C H N O S •2H O. Its molecular weight is 446.43 as the dihydrate. Ceftibuten dihydrate has the following structural formula: CEDAX Capsules contain ceftibuten dihydrate equivalent to 400 mg of ceftibuten. Inactive ingredients contained in the capsule formulation include: magnesium stearate, microcrystalline cellulose, and sodium starch glycolate. The capsule shell and/or band contains gelatin, sodium lauryl sulfate, titanium dioxide, and polysorbate 80. The capsule shell may also contain benzyl alcohol, sodium propionate, edetate calcium disodium, butylparaben, propylparaben, and methylparaben. CEDAX Oral Suspension after reconstitution contains ceftibuten dihydrate equivalent to 180 mg of ceftibuten per 5 mL. CEDAX Oral Suspension is cherry flavored and contains the inactive ingredients: cherry flavoring, polysorbate 80, silicon dioxide, simethicone, sodium benzoate, sucrose (approximately 1 g/5 mL), titanium dioxide, and xanthan gum. CLINICAL PHARMACOLOGY PHARMACOKINETICS Absorption _CEDAX CAPSULES_ ® 15 14 4 6 2 2 Ceftibuten is rapidly absorbed after oral administration of CEDAX Capsules. The plasma concentrations and pharmacokinetic parameters of ceftibuten after a single 400-mg dose of CEDAX Capsules to 12 healthy adult male volunteers (20 to 39 years of age) are displayed in the table below. When CEDAX Capsules were administered once daily for 7 days, the average C was 17.9 µg/mL on day Olvassa el a teljes dokumentumot